DOCSLIB.ORG

The Distribution of T and B Lymphocyte Populations and MHC Class II Expression in Human Fetal and Postnatal Intestine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Distribution of T and B Lymphocyte Populations and MHC Class II Expression in Human Fetal and Postnatal Intestine 0031-3998/90/2703-0239$02.00/0 PEDIATRIC RESEARCH Vol. 27, No.3, 1990 Copyright © 1990 International Pediatric Research Foundation, Inc. Primed in U. SA. The Distribution of T and B Lymphocyte Populations and MHC Class II Expression in Human Fetal and Postnatal Intestine GARY J. RUSSELL, ATUL K. BHAN, AND HARLAND S. WINTER Combined Program in Pediatric Gastroenterology and Nutrition, The Children 's Hospital and the Department of Pathology, M assachusells General Hospital; Harvard Medical School, Boston, M assachusells 02115 ABSTRACT. The development of the intestinal mucosal MATERIALS AND METHODS immune barrier is an important protective adaptation for Tissue samples. Fetal tissues were obtained within 2 h after postnatal life. The distribution and phenotype of T and B prostaglandin/saline-induced abortions. The estimated fertiliza­ lymphocytes in human fetal intestine and lymphoid tissues tion age of the fetuses was determined by crown-rump length, have been characterized and compared to the distribution foot length, and fetal wt during postmortem examination ( 10, and phenotype of lymphocytes in postnatal intestine. The II). The following tissues were harvested from six fetuses, 17- characterization of lymphocyte phenotype and MHC class 21 wk estimated fertilization age: proximal jejunum, distal ileum, II antigen distribution was done using MAb and an avidin­ cecum, colon, spleen, thymus, and liver. Procurement of human biotin complex immunohistochemical staining technique. tissues and the consent forms were approved by the Committee Intraepithelial lymphocytes were occasionally present in for the Protection of Human Subjects from Research Risks at fetal intestine and were primarily CD3+, ens+. T lympho­ the Brigham and Women's Hospital and The Children's Hospi­ cytes were readily identified in the lamina propria of fetal tal, in accordance with the Declaration of Helsinki. intestine, but most were clustered in lymphoid aggregates. Histologically normal intestinal tissue from children ranging Cells identified by anti-IgA and anti-lgA2 were the most 1 in age from I d to 3 y, 10 mo was obtained from surgical numerous cells of B cell lineage in the lamina propria of specimens submitted to the Pathology Department (Table 1). postnatal intestine, whereas lgM+ and lgD+ lymphocytes The tissue samples were embedded in OCT Compound (Ames predominated in fetal tissues. However, lgA-bearing cells Co., Elkhart, IN), snap frozen in liquid nitrogen or isopentane were identified in lymphoid aggregates of the intestine or (-70oC) and stored at -70oC. spleen of some fetuses. This finding suggests that B lym­ MAb. The MAb used in this study include B I (CD20), B2 phocytes can undergo Ig switching in utero. Additionally, (CD21), (Coulter Corp., Hialeah, FL), anti-IgA2, anti­ fetal intestinal epithelial cells did not express MHC class IgG, anti-IgM, anti-IgD, Leu 2a (CDS), Leu 3a (CD4), Leu 4 II antigens, unlike some postnatal intestinal tissues. It is (CD3), Leu 6 (CD!), anti-HLA-DR, anti-HLA-DQ, anti-HLA­ possible that postnatal events such as antigen exposure DP (Becton Dickenson, Mountain View, CA), anti-HLA-A,B,C may be important for the induction of these class II anti­ gens on intestinal epithelial cells. (Pediatr Res 27:239- (Bioproducts for Science Inc., Indianapolis, IN) and OKTS (CDS) (Ortho Pharmaceutical Corp., Raritan, NJ). This panel of 244,1990) antibodies was chosen so that aspects ofB cell, T cell, and antigen presenting cell development could be evaluated. Immunoperoxidase staining. Frozen tissue sections 4- to 6-JLm thick were fixed in acetone and stained by the previously de­ scribed avidin-biotin complex method (12). Briefly, the tissue The postnatal development and maturation of the intestinal sections were incubated with MAb at an optimal dilution for 1 mucosal immune barrier is an important host defense mecha­ h followed by incubations with 1: 240 dilution of biotinylated nism to prevent the penetration and uptake of bacteria, toxins, horse anti-mouse antibody and a I: 120 dilution of avidin-biotin­ and potentially damaging antigens ( 1). Previous reports on the ylated peroxidase complex (Vector Laboratories, Inc., Burlin­ phenotypic characterization and tissue distribution of human game, CA). Negative control slides were incubated with PBS, pH fetal lymphocytes have focused primarily on lymphocytes found 7.3 instead of a primary antibody. A positive control known to in thymus, spleen, liver, lymph nodes, and bone marrow (2-6). express the antigen of interest was also processed in parallel. Limited information is currently available on the development Each incubation was followed by three washes in PBS. Endoge­ of the human gut-associated lymphoid tissue. Immunohisto­ nous peroxidase activity was blocked by a 20-min incubation in chemical examination of human fetal terminal ileum has dem­ 0.3% hydrogen peroxide in PBS. Tissue sections of fetal liver onstrated that by 19-22 wk gestation, the gut epithelium and lamina propria contain many isolated T cells and the lamina propria contains aggregates ofT and B cells (7-9). Our study Table I. Tissue samples ofpo stnatal intestine evaluates the distribution ofT and B lymphoid populations and MHC class II antigen expression in human fetal intestine in Diagnosis Age comparison with normal postnatal intestine. Duodenal atresia ( 1) I d Received June 29, 1989; accepted November 2, 1989. Biliary atresia ( 1) 4 mo Correspondence Gary J. Russell, M.D., Combined Program in Pediatric Gastro­ Intestinal stricture (I) 8 mo enterology and Nutrition Unit, Hunnewell Ground, The Children's Hospital, 300 Hirschsprung's disease ( 1) 14 mo Longwood Ave., Boston, MA 02115. Intussusception (I) 16 mo Supported by a grant from The Hood Foundation to G.J.R., NIH Grant Al- 27747 to H.S.W., and NIH Grant DR-33506 to A.K.B. Choledochal cyst (2) 3 y 10 mo, 6 mo 239 240 RUSSELL ET AL. HUMAN FETAL INTESTINAL LYMPHOCYTES 241 were also incubated with avidin and then biotin (Vector Labo­ Small intestine. The lymphoid cells in the fetal intestinal ratories) before the incubation with biotinylated horse anti­ mucosa were distributed as scattered cells or in small aggregates mouse antibody to block endogenous biotin. The sections were (primary follicles) . Sparsely scattered lymphocytes stained with stained by incubating in a solution of 3-amino-9-ethylcarbazole antibody against CD20, IgM, lgD, and occasionally CD21 and (Aldrich Chemical Co., Inc., Milwaukee, WI), postfixed in 4% were considered to be B lymphocytes. No IgA,+, IgA2+, or IgG+ formaldehyde, counter stained with hematoxylin and mounted cells were present in the lamina propria of fetal intestine or the in Glycergel (Dako Corp., Santa Barbara, CA). proximal jejunum of the 1-d-old infant; however, as expected, IgA, + and IgA2+ cells represented the predominant B cell popu­ RESULTS lation in the lamina propria of postnatal small intestine (Fig. 1b). Lymphocyte staining for IgM, IgD, CD20, and occasionally Thymus. The staining observed in the fetal thymus with anti­ C02! was present in the small intestinal lamina propria of bodies against T cells was consistent with previous report> on postnatal specimens. In order of predominance, CD4+, CD3+, fetal thymocyte suspensions (2, 13) and immunohistochemical and cos+ cells were readily identified in the lamina propria of staining of postnatal thymic tissue ( 14 ). Cortical thymocytes all fetal intestine as well as all specimens obtained postnatally. demonstrated peripheral staining with antibodies against CD1, Many of the CD4+ cells had the morphologic appearance of CD3, CD4, and CDS. The majority of the medullary thymocytes macrophages or dendritic cells. was CD4+ but many were CDS+. IgM+ and IgD+ cells were Most B cells in fetal intestinal tissue were clustered in lymphoid present in the medulla, but no IgG+, IgA, +, or IgA2 + cells were aggregates, characteristic of primary follicles staining with anti­ identified. Many CD20+, and to a lesser extent CD21 +,cells were bodies against IgM, IgD, CD20, and faintly CD21. Many primary found in the medulla. These cells were larger than medium size follicles were present in fetal cecum and appendix. In two spec­ lymphocytes and demonstrated membrane staining. Prominent imens some lgA 1+, lgA2+, and IgG+ cells were prominently diffuse (cytoplasmic) and some membrane staining was present stained in lymphoid aggregates (Fig. I a). in the medulla with the antibodies against MHC class II antigens. Both primary and secondary lymphoid follicles were found in Patchy dendritic staining occurred in the cortex with anti-HLA­ the postnatal specimens except for the 1-d-old infant. Germinal DR and anti-HLA-DQ, but there was minimal cortical staining centers stained for IgM, IgG, and CD20; whereas, the mantle with anti-HLA-DP. This staining pattern was most consistent zones demonstrated the staining characteristics of a primary with the staining of epithelial cells; however, staining of some follicle. Interfollicular cells stained with antibodies against CD4, thymocytes cannot be excluded. CD3, and CDS with CD4+ cells predominating. These results are consistent with the protein that immature Occasional intraepithelial lymphocytes (0-1 cells per high­ thymocytes reside in the cortex and mature thymocytes are powered field) stained with CD3 and CDS antibodies were pres­ present in the medulla; however, the expression of CD3 and ent in all six fetuses and the 1-d-old infant (Fig. 2a). CD4+ CDS antigens by the majority of cortical thymocytes raises the intraepithelial lymphocytes were absent in four fetuses and the possibility that the maturation ofthymocytes starts in the cortex. 1-d-old infant and were observed only rarely in two fetuses. Spleen. B lymphocytes identified with antibodies against IgM, Similarly, intraepithelial lymphocytes that were slightly more IgD, C020, and to a lesser extent CD21, were found mainly in numerous (one to two cells per high-powered field) in the intes­ primary follicles of the white pulp with some cells scattered tine of older infants and children were predominately CD3+ and throughout the red pulp. A few IgA,+ and IgA2+ cells were cos+ (Fig.
Load more

Recommended publications
  • Our Immune System (Children's Book)
    OurOur ImmuneImmune SystemSystem A story for children with primary immunodeficiency diseases Written by IMMUNE DEFICIENCY Sara LeBien FOUNDATION A note from the author The purpose of this book is to help young children who are immune deficient to better understand their immune system. What is a “B-cell,” a “T-cell,” an “immunoglobulin” or “IgG”? They hear doctors use these words, but what do they mean? With cheerful illustrations, Our Immune System explains how a normal immune system works and what treatments may be necessary when the system is deficient. In this second edition, a description of a new treatment has been included. I hope this book will enable these children and their families to explore together the immune system, and that it will help alleviate any confusion or fears they may have. Sara LeBien This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. SECOND EDITION COPYRIGHT 1990, 2007 IMMUNE DEFICIENCY FOUNDATION Copyright 2007 by Immune Deficiency Foundation, USA. Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. Our Immune System may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 40 West Chesapeake Avenue, Suite 308, Towson, MD 21204, USA; or by telephone at 1-800-296-4433.
    [Show full text]
  • Defining Natural Antibodies
    PERSPECTIVE published: 26 July 2017 doi: 10.3389/fimmu.2017.00872 Defining Natural Antibodies Nichol E. Holodick1*, Nely Rodríguez-Zhurbenko2 and Ana María Hernández2* 1 Department of Biomedical Sciences, Center for Immunobiology, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, United States, 2 Natural Antibodies Group, Tumor Immunology Division, Center of Molecular Immunology, Havana, Cuba The traditional definition of natural antibodies (NAbs) states that these antibodies are present prior to the body encountering cognate antigen, providing a first line of defense against infection thereby, allowing time for a specific antibody response to be mounted. The literature has a seemingly common definition of NAbs; however, as our knowledge of antibodies and B cells is refined, re-evaluation of the common definition of NAbs may be required. Defining NAbs becomes important as the function of NAb production is used to define B cell subsets (1) and as these important molecules are shown to play numerous roles in the immune system (Figure 1). Herein, we aim to briefly summarize our current knowledge of NAbs in the context of initiating a discussion within the field of how such an important and multifaceted group of molecules should be defined. Edited by: Keywords: natural antibody, antibodies, natural antibody repertoire, B-1 cells, B cell subsets, B cells Harry W. Schroeder, University of Alabama at Birmingham, United States NATURAL ANTIBODY (NAb) PRODUCING CELLS Reviewed by: Andre M. Vale, Both murine and human NAbs have been discussed in detail since the late 1960s (2, 3); however, Federal University of Rio cells producing NAbs were not identified until 1983 in the murine system (4, 5).
    [Show full text]
  • Lymphocyte Separation Medium (LSM
    THE JOURNAL OF IMMUNOLOGY Bionetics does it for you. Lymphocyte Separation Medium (LSM wenient One-Step Centrifugation Method _ayer diluted blood on LSM. 2,entrifuge for 30-40 min., 18-20°C, ~.00 x g. ~,spirate and discard plasma layer -larvest lymphocyte layer. Quality Control Assurance Each lot is tested for: • Lymphocyte separation and recovery. • Lymphocyte viability. • Sterility. • Consistent density (1.077-1.080 at 20°C). Packaging • Packaged in amber, screw-cap bottles. • 5 x 100 ml bottles per carton. Storage. • Stored at room temperature. Reference Boyum, A. (1968): Isolation of mononuclear cells and granulocytes from human blood. Scand J. Clin. Lab. Invest. 21, Suppl. 97. Aspirate I IC[OI I IC~ LJI Catalog number: 8410-01 & discard serum Lymphocyte For Laboratory Use Aspirate layer & use (mononuclear Please write for our current Price List and Catalog. cells and Original platelets) ITi BIONETICS° LSM layer Erythrocytes Laboratory Products and Litton granulocytes 5516 Nicholson Lane, Kensington, Maryland 20795 Telephone: (301) 881-1557 1979 Litton Bionetics, tnc Get the most out of your high quality cytotoxic antibodies with LOW-TOX-M RABBIT COMPLEMENT LOW TOXICITY HIGH ACTIVITY Presentation: CL 3051 5 x 1 ml, lyophilized $30.00 When it comes to COMPLEMENT... come to CEDARLANE Direct orders or inquiries to: UNITED STATES: WORLDWIDE EXCEPT U.S. ,4 C~L CEDARLANE ACCURATE CHEMICAL & LABORATO RI ES SCIENTIFIC CORPORATION LIMITED 5516-8TH LINE, R.R. 2 28 TEC STREET, HICKSVtLLE, N.Y. 11801 HORNBY, ONTARIO, CANADA LOP 1E0 Telephone
    [Show full text]
  • Stress and the Immune System Tracy B
    4 World Health • 47th Yeor, No. 2, Morch-Aprill994 Stress and the immune system Tracy B. Herbert any people have the effects of factors as diverse as experienced the examinations, bereavement, divorce, Mconnection between stress unemployment, mental arithmetic, and getting sick. Colds, influenza, and looking after a relative with herpes and allergies seem worse Alzheimer's di sease. In general, when we are severely stressed at these studies find that stress is work or in the home. Others are related to changes in both the never sick until they go on vacation numbers of white blood cells in (that is, after the stress is over), and circulation and the quantity of then they spend the whole time antibody in the blood. Moreover, fighting the virus. Because of stress is associated with changes in intrinsic connections like these, the functioning of immune cells. many researchers are today That is, there is a relatively large exploring whether (and how) stress decrease in both lymphocyte and illness are actually linked. One proliferation and natural killer cell specific focus of this research is to activity in individuals who have study the effects of stress on the experienced stress. There seems to immune systems; after all, if stress A lymphocyte: stress may weaken the capacity be some connection between the affects immunity, that would be one of lymphocytes to combat infection. duration of the stress and the amount way in which stress could contribute of immune change. For example, the to illness. longer the stress, the greater the The function of the immune proliferation"- by incubating these decrease in the number of specific system is to protect us from cells for several days with types of white blood cells.
    [Show full text]
  • Med-Pathway Zoom Workshop
    MCAT Immunology Dr. Phillip Carpenter medpathwaymcat Med-pathway AAMC MCAT Content Outline: Immunology Category 1A: Structure/Function of Proteins/AA Immune System Category 3B: Organ Systems Innate vs. Adaptive Immunity T and B Lymphocytes Macrophages & Phagocytes Tissue-Bone marrow, Spleen, Thymus, Lymph nodes Antigen and Antibody Antigen Presentation Clonal Selection Antigen-Antibody recognition Structure of antibody molecule Self vs. Non-self, Autoimmune Diseases Major Histocompatibility Complex Lab Techniques: ELISA & Western Blotting Hematopoiesis Creates Immune Cells Self vs. Non-self Innate vs Adaptive Innate Immunity Physical Barriers: Skin, mucous membranes, pH Inflammatory mediators: Complement, Cytokines, Prostaglandins Cellular Components: Phagocytes-Neutrophils, Eosinophils, Basophils, Mast Cells Antigen Presenting Cells-Monocytes, Macrophages, Dendritic Cells Adaptive (Acquired) Immunity Composed of B and T lymphocytes: Activated by Innate Immunity B cells: Express B cell receptor and secrete antibodies as plasma cells T cells: Mature in thymus, express TCR surface receptor; Activated by Antigen Presenting Cells (APCs) Direct Immune response (The Ringleaders of immune system) Major Lymphoid Organs TYPE SITE FUNCTION Fetal production of Liver 1° lymphoid cells Hematopoietic production of 1° Bone marrow myeloid and lymphoid cells Receives bone marrow T 1° Thymus cells; site where self is selected from non-self Lymph nodes 2° Sites of antigen activation Spleen of lymphocytes; clearance Macrophages (Sentinel Cells) Pattern Recognition
    [Show full text]
  • Association Between Neutrophil-Lymphocyte Ratio and Herpes Zoster Infection in 1688 Living Donor Liver Transplantation Recipients at a Large Single Center
    biomedicines Article Association between Neutrophil-Lymphocyte Ratio and Herpes Zoster Infection in 1688 Living Donor Liver Transplantation Recipients at a Large Single Center Ji-Hoon Sim, Young-Jin Moon, Sung-Hoon Kim, Kyoung-Sun Kim , Ju-Seung Lee, Jun-Gol Song * and Gyu-Sam Hwang Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea; [email protected] (J.-H.S.); [email protected] (Y.-J.M.); [email protected] (S.-H.K.); [email protected] (K.-S.K.); [email protected] (J.-S.L.); [email protected] (G.-S.H.) * Correspondence: [email protected]; Tel.: +82-2-3010-3869 Abstract: Liver transplantation (LT) is closely associated with decreased immune function, a contrib- utor to herpes zoster (HZ). However, risk factors for HZ in living donor LT (LDLT) remain unknown. Neutrophil-lymphocyte ratio (NLR) and immune system function are reportedly correlated. This study investigated the association between NLR and HZ in 1688 patients who underwent LDLT between January 2010 and July 2020 and evaluated risk factors for HZ and postherpetic neuralgia (PHN). The predictive power of NLR was assessed through the concordance index and an integrated discrimination improvement (IDI) analysis. Of the total cohort, 138 (8.2%) had HZ. The incidence of HZ after LT was 11.2 per 1000 person-years and 0.1%, 1.3%, 2.9%, and 13.5% at 1, 3, 5, and 10 years, Citation: Sim, J.-H.; Moon, Y.-J.; Kim, respectively. In the Cox regression analysis, preoperative NLR was significantly associated with HZ S.-H.; Kim, K.-S.; Lee, J.-S.; Song, J.-G.; (adjusted hazard ratio [HR], 1.05; 95% confidence interval [CI], 1.02–1.09; p = 0.005) and PHN (HR, Hwang, G.-S.
    [Show full text]
  • Homeostatic and Activated Conditions Cell
    The Journal of Immunology Dynamics of the Splenic Innate-like CD19+CD45Rlo Cell Population from Adult Mice in Homeostatic and Activated Conditions Bele´n de Andre´s,*,1 Carmen Prado,* Beatriz Palacios,* Mario Alı´a,* Sharmili Jagtap,† Natalia Serrano,† Isabel Cortegano,* Miguel Angel R. Marcos,† and Maria Luisa Gaspar*,1 In the adult spleen, CD19+CD45R2/lo (19+45Rlo) lymphocytes of embryonic origin exist as a distinct population to that of the conventional B cell lineage. These cells display a plasmablast phenotype, and they spontaneously secrete IgG1 and IgA, whereas the bone marrow population of 19+45Rlo cells contains B1 progenitors. In this study, we show that 19+45Rlo cells are also present in Peyer’s patches and in the spleen throughout the life span of wild-type mice, beginning at postnatal day 7. Although this population is heterogeneous, the surface phenotype of most of these cells distinguishes them from follicular, transitional, marginal zone, and B1 cells. In CBA/CaHN mice, few 19+45Rlo cells were detected at postnatal day 7, and none was observed in the adult spleen. Splenic 19+45Rlo cells exhibited homeostatic BrdU uptake in vivo and actively transcribed cell cycle genes. When trans- ferred to immunodeficient RAG22/2gchain2/2 recipient mice, 19+45Rlo cells survived and differentiated into IgG1– and IgA– plasma cells. Moreover, in vitro stimulation of splenic 19+45Rlo cells with LPS, CpG, BAFF/IL4, and CD40/IL4 induced cell proliferation, IgG1/IgA secretion and the release of IL-10, suggesting a potential immunoregulatory role for this subset of innate- like B cells. The Journal of Immunology, 2012, 189: 2300–2308.
    [Show full text]
  • Lymphocyte-Activation Gene 3 (LAG-3) Immune Pathway
    Lymphocyte-Activation Gene 3 (LAG-3) About LAG-3 LAG-3 Lymphocyte-activation gene 3 (LAG-3) is an immune checkpoint receptor protein found on the cell surface of effector T cells and regulatory T cells (Tregs) and functions to control T cell response, activation and growth.1 TCR T cells are a type of white blood cell that are part of the immune system. Activation of cytotoxic T cells by antigens enables them to 1 kill unhealthy or foreign cells. Inactive T cell Antigen MHC Dendritic cell (APC) LAG-3 and LAG-3 and LAG-3 and Immune Function T Cell Exhaustion Cancer • After a T cell is activated to kill its • However, in certain situations where T • Because of its critical role in regulating target cell, LAG-3 expression is cells experience prolonged exposure to an exhaustion of cytotoxic T cells and Treg increased to turn off the immune antigen, such as cancer or chronic function, LAG-3 has become a target of response, so that the T cell does not go infection, the T cells become desensitized study in the cancer field. on to attack healthy cells.2 and lose their ability to activate and multiply in the presence of the antigen.4 • In cancer, LAG-3 expressing exhausted • Inhibition of the immune response is cytotoxic T cells and Tregs expressing accomplished through activation of • The desensitized T cell will also LAG-3 gather at tumor sites.5,6 the LAG-3 pathway, which can occur progressively fail to produce cytokines via binding of LAG-3 to a type of (proteins that assist in the immune • Preclinical studies suggest that inhibiting antigen-presenting complex called response) and kill the target cells.4 LAG-3 allows T cells to regain their MHC II.
    [Show full text]
  • Understanding the Immune System: How It Works
    Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute NIH Publication No. 03-5423 September 2003 www.niaid.nih.gov www.nci.nih.gov Contents 1 Introduction 2 Self and Nonself 3 The Structure of the Immune System 7 Immune Cells and Their Products 19 Mounting an Immune Response 24 Immunity: Natural and Acquired 28 Disorders of the Immune System 34 Immunology and Transplants 36 Immunity and Cancer 39 The Immune System and the Nervous System 40 Frontiers in Immunology 45 Summary 47 Glossary Introduction he immune system is a network of Tcells, tissues*, and organs that work together to defend the body against attacks by “foreign” invaders. These are primarily microbes (germs)—tiny, infection-causing Bacteria: organisms such as bacteria, viruses, streptococci parasites, and fungi. Because the human body provides an ideal environment for many microbes, they try to break in. It is the immune system’s job to keep them out or, failing that, to seek out and destroy them. Virus: When the immune system hits the wrong herpes virus target or is crippled, however, it can unleash a torrent of diseases, including allergy, arthritis, or AIDS. The immune system is amazingly complex. It can recognize and remember millions of Parasite: different enemies, and it can produce schistosome secretions and cells to match up with and wipe out each one of them.
    [Show full text]
  • A Novel BCMA/CD3 Bispecific T-Cell Engager for the Treatment
    OPEN Leukemia (2017) 31, 1743–1751 www.nature.com/leu ORIGINAL ARTICLE A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo S Hipp1, Y-T Tai2,3, D Blanset4, P Deegen5, J Wahl5, O Thomas5, B Rattel5, PJ Adam1, KC Anderson2,3 and M Friedrich5 B-cell maturation antigen (BCMA) is a highly plasma cell-selective protein that is expressed on malignant plasma cells of multiple myeloma (MM) patients and therefore is an ideal target for T-cell redirecting therapies. We developed a bispecific T-cell engager (BiTE) targeting BCMA and CD3ε (BI 836909) and studied its therapeutic impacts on MM. BI 836909 induced selective lysis of BCMA- positive MM cells, activation of T cells, release of cytokines and T-cell proliferation; whereas BCMA-negative cells were not affected. Activity of BI 836909 was not influenced by the presence of bone marrow stromal cells, soluble BCMA or a proliferation-inducing ligand (APRIL). In ex vivo assays, BI 836909 induced potent autologous MM cell lysis in both, newly diagnosed and relapsed/ refractory patient samples. In mouse xenograft studies, BI 836909 induced tumor cell depletion in a subcutaneous NCI-H929 xenograft model and prolonged survival in an orthotopic L-363 xenograft model. In a cynomolgus monkey study, administration of BI 836909 led to depletion of BCMA-positive plasma cells in the bone marrow. Taken together, these results show that BI 836909 is a highly potent and efficacious approach to selectively deplete BCMA-positive MM cells and represents a novel immunotherapeutic for the treatment of MM.
    [Show full text]
  • B-Cell Lymphomas Differ in Their Responsiveness to Cpg Oligodeoxynucleotides
    1490 Vol. 11, 1490–1499, February 15, 2005 Clinical Cancer Research B-Cell Lymphomas Differ in their Responsiveness to CpG Oligodeoxynucleotides Bernd Jahrsdorfer,5 Lars Mu¨hlenhoff,1 responsiveness to CpG oligodeoxynucleotides. Focusing Sue E. Blackwell,5 Moritz Wagner,1 clinical studies on patients with highly CpG oligodeoxynu- cleotide–sensitive B-cell malignancies may improve the Hendrik Poeck,1 Evelyn Hartmann,3 Ralf Jox,1 clinical outcome of such trials. Thomas Giese,4 Bertold Emmerich,2 Stefan Endres,1 5 1 George J. Weiner, and Gunther Hartmann INTRODUCTION 1 2 Division of Clinical Pharmacology and Department of Internal The vast majority of lymphoid neoplasms worldwide are Medicine, Division of Hematology, and 3Department of Otorhinolaryngology, University of Munich, Munich, Germany; derived from B lymphocytes at various stages of differentiation. 4Institute of Immunology, University of Heidelberg, Heidelberg, Neoplasms originating from precursor B cells are rare. Neo- Germany; and 5Holden Comprehensive Cancer Center and plasms derived from mature naive B cells include B-cell chronic Department of Internal Medicine, University of Iowa, Iowa City, Iowa lymphocytic leukemia (B-CLL), B-cell small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). Follicular lymphoma (FL) and diffuse large B-cell lymphoma (LCL) are ABSTRACT derived from germinal center B cells. Memory B cells can Human B cells detect CpG motifs within microbial DNA develop into marginal zone B-cell lymphoma (MZL) and B- via TLR9. Synthetic CpG oligodeoxynucleotides are currently CLL. Plasmacytoma is related to plasma cells (1). The most being tested in clinical trials for the therapy of different types typical lymphomas are of diffuse large B-cell type (33%) of B cell non-Hodgkin’s lymphoma.
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]